A new daily pill could be a more effective GLP-1 tablet for weight loss, according to a clinical trial that may pave the way for an improved non-injection alternative to Wegovy and Mounjaro.
Be the first to know!
。业内人士推荐谷歌浏览器【最新下载地址】作为进阶阅读
Anthropic CEO Dario Amodei (Photo by David Dee Delgado/Getty Images for The New York Times)David Dee Delgado via Getty Images
Access to affordable childcare remains a major constraint, and high income taxes and complex benefits can discourage people, especially second earners, from working more hours.